Abstract
Liposome is a vesicle composed of a lipid bilayer and widely used as a drug carrier for injectable formulation of drugs and targeting drug delivery system. On the other hand, because an antibody has a potential to strongly and specifically recognize a targeted molecule, it can be said that utilizing the antibody in DDS achieves effective drug delivery to a targeted site such as tumor tissue and ideal medication. In this review, we describe the outline of antibody-modified liposome for active targeting DDS and introduce our recent research on tumor targeting using the antibody-modified liposomes for cancer chemotherapy.
